Your browser doesn't support javascript.
loading
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy.
Rose, Tracy L; Chism, David D; Alva, Ajjai S; Deal, Allison M; Maygarden, Susan J; Whang, Young E; Kardos, Jordan; Drier, Anthony; Basch, Ethan; Godley, Paul A; Dunn, Mary W; Kim, William Y; Milowsky, Matthew I.
Afiliación
  • Rose TL; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Chism DD; Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Alva AS; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Maygarden SJ; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Whang YE; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kardos J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Drier A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Basch E; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Godley PA; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Dunn MW; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kim WY; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Milowsky MI; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. matt_milowsky@med.unc.edu.
Br J Cancer ; 119(7): 801-807, 2018 10.
Article en En | MEDLINE | ID: mdl-30293995
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Carcinoma de Células Transicionales / Neoplasias Urológicas / Inhibidor p16 de la Quinasa Dependiente de Ciclina / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Carcinoma de Células Transicionales / Neoplasias Urológicas / Inhibidor p16 de la Quinasa Dependiente de Ciclina / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos